Categories AlphaGraphs, Earnings, Health Care
VRTX Earnings: Highlights of Vertex Pharmaceuticals’ Q3 2023 results
Healthcare company Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) on Monday reported an increase in revenues for the third quarter of 2023. The company also provided guidance for fiscal 2023.
September-quarter earnings, adjusted for special items, moved up to $4.08 per share from $4.01 per share in the same period of 2022. Unadjusted profit was $1.04 billion or $3.97 per share, vs. $930.5 million or $3.59 per share a year earlier.
The company said that third-quarter revenues increased to $2.48 billion from $2.33 billion in the year-ago period. For the whole of fiscal 2023, the management expects total product revenues to be in the range of $9.85 billion.
Prior Performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Infographic: How Deere & Company (DE) performed in Q2 2024
Deere & Company (NYSE: DE) reported second quarter 2024 earnings results today. Total net sales and revenues decreased 12% year-over-year to $15.2 billion. Net income was $2.37 billion, or $8.53
WMT Earnings: Key quarterly highlights from Walmart’s Q1 2025 financial results
Walmart Inc. (NYSE: WMT) reported its first quarter 2025 earnings results today. Consolidated revenue increased 6% year-over-year to $161.5 billion. Revenue growth on a constant currency basis was 5.8%. Consolidated
Home Depot (HD): A look at how the home improvement retailer fared in Q1 2024
Shares of Home Depot (NYSE: HD) rose over 2% on Wednesday. The stock has gained 19% over the past 12 months. The company delivered mixed results for the first quarter
